Hepatitis C Treatment Options - YOU ARE HERE:

YOU ARE HERE:
Aidsmap - Jan 10 5:02 PM
Prolonged high HIV viral loads are associated with an increased risk of non-Hodgkin's lymphoma (NHL) independent of CD4 cell counts, according to data from the French Aquitaine Cohort published in the February 1 st edition of Clinical Infectious Diseases . The investigators found that the risk of NHL decreased after six months or longer of highly active antiretroviral therapy (HAART). In Save to My Web

InterMune Completes Divestiture of Infergen(R) for up to $135.5 Million in Cash
FinanzNachrichten - Jan 03 5:47 AM
BRISBANE, Calif., Jan. 3 /PRNewswire-FirstCall/ -- InterMune, ( Nachrichten ) Inc. announced today the completion of the sale of its United States and Canadian rights to Infergen(R) (interferon alfacon-1), approved for the treatment of chronic hepatitis C virus (HCV) infections, to Valeant Pharmaceuticals International .Save to My Web